MEDICATION DISCOVERY USING RAT MODELS OF RELAPSE TO DRUG SELF-ADMINISTRATION

RELEASE DATE:  May 14, 2004

NOTICE:  NOT-DA-04-027

RFP AVAILABLE:  N01DA-4-8848        

National Institute on Drug Abuse (NIDA)
 (http://www.nida.nih.gov/)

The National Institute on Drug Abuse, plans to solicit proposals from 
qualified organizations having in-house capability to develop 
methodologies and to perform in vivo rodent behavioral pharmacology 
studies of potential pharmacotherapies for cocaine dependence, as well 
as potential pharmacotherapies for other drug dependence disorders, 
using drug self-administration reinstatement models. The Contractor 
will be blinded to the identity of proprietary test compounds, the 
compounds will be evaluated in established assays, and the resulting 
data will be utilized by the NIDA Division of Treatment Research and 
Development. In order to handle substances under the Controlled 
Substances Act of 1970, it is mandatory that offerors possess a DEA 
Research Registration for Schedules II to V and demonstrate the 
capability to obtain a DEA registration for Schedule I controlled 
substances. All offerors must be in compliance with the NIH guidelines 
on the care and use of laboratory animals. NIDA expects to award a 5-
year contract with options for additional quantities. NIDA anticipates 
that this solicitation will result in the award of multiple contracts. 
RFP No. N01DA-4-8848 is available electronically. You can access the 
RFP through the FedBizOpps (URL: http://www.fedbizopps.gov or through 
the NIDA website at the following address: (URL: 
http://www.nida.nih.gov/RFP/RFPList.html). Please note that the RFP for 
this acquisition is streamlined to include only the Work Statement, 
Deliverables, Reporting Requirements, Special Requirements, Mandatory 
Qualifications, Technical Evaluation Criteria, and other necessary 
Proposal Preparation Instructions.  However, all information required 
for the submission of an offer is contained in or accessible through 
the streamlined electronic RFP package. This advertisement does not 
commit the Government to award a contract. Proposals are due on May 21, 
2004.  

Point of Contact:

Diane M. Loeb, Contract Specialist
National Institute on Drug Abuse, NIH
Contracts Management Branch, OPRM
6101 Executive Boulevard
Room 260, MSC 8402
Bethesda, Maryland  20892-8402
Electronic Mail Address: dl294p@nih.gov
Telephone:  (301) 443-6677
Fax:  (301) 443-7595

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.